A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Trial Profile

A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms COMPEL
  • Sponsors Allergan
  • Most Recent Events

    • 10 Sep 2017 Results presented at the 2017 International Headache Society
    • 10 Sep 2017 Results of subgroup analysis assessing the effects of onabotulinumtoxinA prophylaxis on comorbid psychiatric symptoms of anxiety and depression, were presented at the 2017 International Headache Society.
    • 10 Sep 2017 Results of subgroup analysis assessing the efficacy of onabotulinumtoxinA treatment on disability and quality of life in patients with chronic migraine with baseline headache every day, were presented at the 2017 International Headache Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top